These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 38844562)

  • 1. Signaling pathways in colorectal cancer implications for the target therapies.
    Song Y; Chen M; Wei Y; Ma X; Shi H
    Mol Biomed; 2024 Jun; 5(1):21. PubMed ID: 38844562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel targeting approaches and signaling pathways of colorectal cancer: An insight.
    Tiwari A; Saraf S; Verma A; Panda PK; Jain SK
    World J Gastroenterol; 2018 Oct; 24(39):4428-4435. PubMed ID: 30357011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic strategies targeting Wnt/β‑catenin signaling for colorectal cancer (Review).
    Ji Y; Lv J; Sun D; Huang Y
    Int J Mol Med; 2022 Jan; 49(1):. PubMed ID: 34713301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deciphering the functional landscape and therapeutic implications of noncoding RNAs in the TGF-β signaling pathway in colorectal cancer: A comprehensive review.
    Saadh MJ; Allela OQB; Sattay ZJ; Al Zuhairi RAH; Ahmad H; Eldesoky GE; Adil M; Ali MS
    Pathol Res Pract; 2024 Mar; 255():155158. PubMed ID: 38320438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel and Emerging Targeted Therapies of Colorectal Cancer.
    Finnberg N; Gokare P; El-Deiry WS
    Curr Clin Pharmacol; 2015; 10(4):279-98. PubMed ID: 26548905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Targets in Precision Chemoprevention of Colorectal Cancer: An Update from Pre-Clinical to Clinical Trials.
    Yarla NS; Madka V; Pathuri G; Rao CV
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Molecular Biology to Clinical Trials: Toward Personalized Colorectal Cancer Therapy.
    Palma S; Zwenger AO; Croce MV; Abba MC; Lacunza E
    Clin Colorectal Cancer; 2016 Jun; 15(2):104-15. PubMed ID: 26777471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor: pathway, therapies, and pipeline.
    Goffin JR; Zbuk K
    Clin Ther; 2013 Sep; 35(9):1282-303. PubMed ID: 24054705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting cancer stem-like cells in glioblastoma and colorectal cancer through metabolic pathways.
    Kahlert UD; Mooney SM; Natsumeda M; Steiger HJ; Maciaczyk J
    Int J Cancer; 2017 Jan; 140(1):10-22. PubMed ID: 27389307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Navigating Molecular Pathways: An Update on Drugs in Colorectal Cancer Treatment.
    Maurya NS; Mani A
    Curr Top Med Chem; 2023; 23(30):2821-2843. PubMed ID: 37317918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of Gene Mutations in Colorectal Cancer: Implications for Treatment.
    Dienstmann R; Tabernero J
    Cancer J; 2016; 22(3):149-55. PubMed ID: 27341591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancements in combining targeted therapy and immunotherapy for colorectal cancer.
    Singh M; Morris VK; Bandey IN; Hong DS; Kopetz S
    Trends Cancer; 2024 Jul; 10(7):598-609. PubMed ID: 38821852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma.
    Li X; Nie J; Mei Q; Han WD
    World J Gastroenterol; 2016 Jun; 22(23):5317-31. PubMed ID: 27340348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer.
    Stiegelbauer V; Perakis S; Deutsch A; Ling H; Gerger A; Pichler M
    World J Gastroenterol; 2014 Sep; 20(33):11727-35. PubMed ID: 25206276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor and epidermal growth factor signaling pathways as therapeutic targets for colorectal cancer.
    Winder T; Lenz HJ
    Gastroenterology; 2010 Jun; 138(6):2163-76. PubMed ID: 20420953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity and resistance to KRAS
    Ye W; Lu X; Qiao Y; Ou WB
    Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189108. PubMed ID: 38723697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal transduction pathways of the epidermal growth factor receptor in colorectal cancer and their inhibition by small molecules.
    Efferth T
    Curr Med Chem; 2012; 19(33):5735-44. PubMed ID: 23033949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-colorectal cancer biotargets and biological mechanisms of puerarin: Study of molecular networks.
    Li J; Guo C; Lu X; Tan W
    Eur J Pharmacol; 2019 Sep; 858():172483. PubMed ID: 31233753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular signaling pathways implicated in metastasis of colorectal cancer and the associated targeted agents.
    Liu X; Ji Q; Fan Z; Li Q
    Future Oncol; 2015; 11(21):2911-22. PubMed ID: 26414153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene mutation profiling in microsatellite instability colorectal cancer and its association with the efficacy of immunotherapy: A retrospective study.
    Liu Y; Cui K; Ma W
    Cancer Med; 2024 May; 13(9):e6910. PubMed ID: 38746969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.